On 17 october 2015, china's car-t multi-centre clinical research project was officially launched in tianjin. The project will establish clinical research centres in 18 hospitals and involve more than 40 specialists in clinical research over a period of two years, with the aim of evaluating the safety and clinical effectiveness of car-t technology for the treatment of re-emerging/diffic blood tumours and providing a basis for wider application to